CAS 89-25-8
:Edaravone
Descrizione:
Edaravone, con il numero CAS 89-25-8, è un composto sintetico riconosciuto principalmente per le sue proprietà neuroprotettive. È classificato come un catturatore di radicali liberi, il che significa che può neutralizzare i radicali liberi dannosi nel corpo, riducendo così lo stress ossidativo. Questa caratteristica lo rende particolarmente rilevante nel trattamento delle malattie neurodegenerative, come la sclerosi laterale amiotrofica (SLA) e l'ictus ischemico acuto. Edaravone è tipicamente presentato come un liquido incolore o giallo pallido ed è solubile in acqua, il che facilita la sua somministrazione in contesti clinici. Il composto ha un peso molecolare relativamente basso e presenta un livello moderato di lipofilia, consentendogli di penetrare efficacemente nelle membrane biologiche. Il suo meccanismo d'azione implica l'inibizione della perossidazione lipidica e la protezione delle cellule neuronali dai danni ossidativi. Edaravone è stato studiato ampiamente per il suo potenziale terapeutico e, sebbene sia generalmente ben tollerato, può avere effetti collaterali che richiedono monitoraggio durante il trattamento.
Formula:C10H10N2O
InChI:InChI=1S/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-6H,7H2,1H3
InChI key:InChIKey=QELUYTUMUWHWMC-UHFFFAOYSA-N
SMILES:O=C1N(N=C(C)C1)C2=CC=CC=C2
Sinonimi:- 1,3,5-Pmp
- 1-Fenil-3-Metil-5-Pirazolona
- 1-Phenyl-3-Methyl-5-Prazalone
- 1-Phenyl-3-Methyl-5-Pyrazole
- 1-Phenyl-3-Methyl-5-Pyrazolone
- 1-Phenyl-3-methyl-1H-4,5-dihydropyrazol-5-one
- 1-Phenyl-3-methyl-2-pyrazolin-5-one
- 1-Phenyl-3-methyl-5-oxopyrazole
- 1-Phenyl-3-methyl-5-pyrazolinone
- 2,4-Dihydro-5-Methyl-2-Phenyl-3H-Pyrazol-3-On
- 2,4-Dihydro-5-Methyl-2-Phenyl-3H-Pyrazol-3-One
- 2,4-Dihydro-5-methyl-2-phenyl-3H-pyrazole-3-one
- 2-Pyrazolin-5-one, 3-methyl-1-phenyl-
- 3-Methyl-1-phenyl-1H-pyrazol-5(4H)-one
- 3-Methyl-1-phenyl-1H-pyrazol-5-one
- 3-Methyl-1-phenyl-2-pyrazoline-5-one
- 3-Methyl-1-phenyl-4,5-dihydro-1H-pyrazol-5-one
- 3-Methyl-1-phenyl-4,5-dihydropyrazol-5-one
- 3-Methyl-1-phenyl-4,5-dihydropyrazole-5-one
- 3-Methyl-1-phenyl-5-pyrazolon
- 3-Methyl-1-phenyl-5-pyrazolone
- 3-Methyl-1-phenylpyrazol-5(4H)-one
- 3-Methyl-1-phenylpyrazol-5-one
- 3-Methyl-1-phenylpyrazole-5-one
- 3-Methyl-1-phenylpyrazolin-5-one
- 3H-Pyrazol-3-one, 2,4-dihydro-5-methyl-2-phenyl-
- 4,5-Dihydro-3-methyl-5-oxo-1-phenylpyrazole
- 5-Methyl-2-phenyl-1,2-dihydropyrazol-3-one
- 5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one
- 5-Methyl-2-phenyl-2,4-dihydropyrazol-3-one
- 5-Methyl-2-phenyl-2H-pyrazol-3(4H)-one
- 5-Methyl-2-phenylpyrazol-3-one
- Developer Z
- Edarabone
- Edaravon
- Edaravone
- Edvaradone
- Mci-186
- Methylphenylpyrazolone
- Nci-C 03952
- Norantipyrine
- Norphenazone
- Nsc 12
- Nsc 26139
- Nsc 2629
- PMP
- Phenylmethyl pyrazolone
- Pyrazolin(2)-5-One, 3-Methyl-1-Phenyl-
- Radicava
- Radicut
- C.I. Developer 1
- Vedi altri sinonimi
Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
17 prodotti.
3-Methyl-1-phenyl-5-pyrazolone
CAS:Formula:C10H10N2OPurezza:>98.0%(T)(HPLC)Colore e forma:White to Orange to Green powder to crystalPeso molecolare:174.203-Methyl-1-phenyl-2-pyrazolin-5-one, 98+%
CAS:<p>3-Methyl-1-phenyl-2-pyrazolin-5-one used as reagent for detection of reducing carbohydrates by ESI/MALDI -MS. This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original A</p>Formula:C10H10N2OPurezza:98+%Colore e forma:Pale cream to cream to yellow to pale brown, PowderPeso molecolare:174.20Antipyrine Related Compound A (3-Methyl-1-phenyl-1H-pyrazol-5(4H)-one)
CAS:<p>Aromatic or modified aromatic compounds containg an unfused pyrazolering (whether or not hydrogenated) in the structure</p>Formula:C10H10N2OColore e forma:White Pale Yellow PowderPeso molecolare:174.07931Edaravone
CAS:<p>Edaravone (MCI-186)(MCI-186) is a potent new free radical scavenger used for the therapy of patients with acute brain infarction.</p>Formula:C10H10N2OPurezza:99.44% - >99.99%Colore e forma:Pale Yellow Solid Solid Particulate/PowderPeso molecolare:174.201-Phenyl-3-methyl-5-pyrazolone
CAS:<p>1-Phenyl-3-methyl-5-pyrazolone</p>Formula:C10H10N2OPurezza:98%Colore e forma: yellow crystalline powderPeso molecolare:174.20g/mol1-Phenyl-3-methyl-5-pyrazolone
CAS:Formula:C10H10N2OPurezza:≥ 98.0%Colore e forma:White to yellow to brown powder or crystalsPeso molecolare:174.205-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one (Edaravone)
CAS:Formula:C10H10N2OColore e forma:NeatPeso molecolare:174.203-Methyl-1-phenyl-2-pyrazolin-5-one(Edaravone)
CAS:Prodotto controllato<p>Impurity Phenazone EP Impurity A<br>Applications Edaravone inhibits the disease activity in rheumatoid arthritis. Edaravone can significantly enhance IR flap viability and protect flap vessels, which is related to scavenging oxygen free radicals, reducing the consumption of SOD, reducing the extent of lipid peroxidation and inflammation, and protecting functional structure of vessels in the early stages of reperfusion. It also shows protective effects against STZ-induced cognitive impairment, oxidative stress, cholinergic dysfunction and altered protein expressions. Its acts like a free radical scavenger, decreased apoptotic cell death, oxidative damage to DNA and lipids, and angiogenesis through inhibiting JNK and p38 MAPK pathways in AMD, glaucoma, DR, and RVO animal models.<br>References Reeta KH et al. Eur J Neurosci. 2017 Feb 15Masuda T et al. Oxid Med Cell Longev. 2017;2017:9208489Zhang DY et al. J Huazhong Univ Sci Technolog Med Sci. 2017 Feb;37(1):51-56Criswell LA et al. Am J Med. 2002 Apr 15;112(6):465-71.<br></p>Formula:C10H10N2OColore e forma:NeatPeso molecolare:174.20Ref: ST-EA-CP-A104005
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta3-Methyl-1-phenyl-2-pyrazoline-5-one
CAS:Formula:C10H10N2OPurezza:95%Colore e forma:SolidPeso molecolare:174.203Edaravone
CAS:<p>Edaravone is a drug that belongs to the class of radical scavengers and has been shown to be effective in reducing neuronal death by blocking the mitochondrial permeability transition pore. It also protects against oxidative injury by inhibiting lipid peroxidation, protein nitration, and DNA damage. Edaravone has been shown to be effective in treating bowel disease and possibly other inflammatory diseases such as sepsis. Edaravone is injected intravenously and can be used as an injection solution with dextran sulfate due to its low solubility in water. Edaravone binds reversibly to the toll-like receptor 4 (TLR4) and inhibits TLR4-mediated signaling pathways, which may lead to a reduction of inflammation.</p>Formula:C10H10N2OPurezza:Min. 98%Colore e forma:PowderPeso molecolare:174.2 g/molEdaravone
CAS:<p>Aromatic or modified aromatic compounds containg an unfused pyrazolering (whether or not hydrogenated) in the structure</p>Formula:C10H10N2OPeso molecolare:174.07931















